| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/18/2004 | US20040054135 Calcineurin polypeptide for diagnosis and treatment of cardiovascular disorders |
| 03/18/2004 | US20040054133 Multiple sclerosis-related superantigen |
| 03/18/2004 | US20040054129 Novel peptides and compositions which modulate apoptosis |
| 03/18/2004 | US20040053941 Substituted pyrazine derivatives |
| 03/18/2004 | US20040053919 Administering a patient suffering from arthritic diseases, a 1,4-benzodiazapine or a 1,4-benzothiazepine derivative for treating such degenerative joint diseases |
| 03/18/2004 | US20040053907 Cell adhesion inhibitors |
| 03/18/2004 | US20040053867 Nucleotide sequences that code for transport proteins; modulation of excitatory amino acids or signal tranduction; detoxification |
| 03/18/2004 | US20040053853 Topiramate salts and compositions comprising and methods of making and using the same |
| 03/18/2004 | US20040053845 Modified peptides as therapeutic agents |
| 03/18/2004 | US20040053839 Modulating apoptosis in a cell by administration of an apoptosis-modulating effective amount of an agent which interferes with prion protein-bax interaction |
| 03/18/2004 | US20040053838 Measuring serum IGF-I and/or IGF-I binding protein levels after birth of patient to obtain IGF-I or IGF-I binding protein level and correlating said level with in utero baseline level based on gestational age matched mean levels |
| 03/18/2004 | US20040053833 Relates to regulation of activity of NET (ERP/SAP-2) protein and to compounds which modify or regulate NET protein activity; methods of screening for agonists or antagonists of NET in order to identify new pro- or anti-angiogenic compounds |
| 03/18/2004 | US20040053830 Use of protein (BCMP84) isolated from breast cancer cell line membrane preparations, compositions comprising protein, vaccines, antibodies immunospecific for protein in diagnosis, treatment, prophylaxis of breast, bladder, tonsil cancer |
| 03/18/2004 | US20040053426 Method of immunity examination with insoluble carrier particle and reagent therefor |
| 03/18/2004 | US20040053425 Quantitative measurement of proteins using genetically-engineeredglucose oxidase fusion molecules |
| 03/18/2004 | US20040053424 On-line detection of ligand/affinity complexes using spectrum analysis |
| 03/18/2004 | US20040053423 Lateral flow immunoassay device employing paramagnetic particles to label and quantify target analytes; microfluidics |
| 03/18/2004 | US20040053419 Test device |
| 03/18/2004 | US20040053415 Ozone-in-water decay rate analyzer |
| 03/18/2004 | US20040053407 Propagating mucified oocyte and/or urogential complexes in oil-free broth; genetic and tissue engineering; in vitro fertilization |
| 03/18/2004 | US20040053403 Microfluidic devices and methods |
| 03/18/2004 | US20040053402 Preparation of fluid samples by applying pressure |
| 03/18/2004 | US20040053399 Optical evaluation of conjugated nucleotide sequence probes; diagnostic beacons for genetic analysis |
| 03/18/2004 | US20040053398 Determination of recombinant glycosylated proteins and peptides in biological fluids |
| 03/18/2004 | US20040053393 Comprises genetically engineered bacteriophage polymerase for detection and treatment of microorganismal infections |
| 03/18/2004 | US20040053392 Thrombospondin fragments and uses thereof in clinical assays for cancer and generation of antibodies and other binding agents |
| 03/18/2004 | US20040053390 Generating mutant aminoacyl transfer RNA synthetase for de novo design of artificial proteins |
| 03/18/2004 | US20040053386 Terpene synthase having a region with 20% or greater sequence identity to specific residues of perferential amino acid sequence, and such synthase containing nine alpha-carbon having interatomic distance +-2.3 Angstroms between alpha C |
| 03/18/2004 | US20040053379 Method of producing polyunsaturated fatty acids, novel biosynthesis genes, and novel plant expression constructs |
| 03/18/2004 | US20040053372 Comprises prothrombin amino acid sequences for treating thrombosis and blood disorders |
| 03/18/2004 | US20040053371 Comprises immunoglobulins for detection and treatment of alzheimer's disease; immunotherapy |
| 03/18/2004 | US20040053358 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/18/2004 | US20040053356 Accurately and rapidly determining amino acid sequence of proteins via reversible immobilization of peptide on solid supports; in vitro translation and genetic engineering |
| 03/18/2004 | US20040053354 Methods for optically immobilizing very small objects and their use |
| 03/18/2004 | US20040053353 Apparatus comprised of plant cells for detecting presence of biological and chemical agents, especially biohazardous and environmental toxins |
| 03/18/2004 | US20040053352 Diagnostics based on tetrazolium compounds |
| 03/18/2004 | US20040053351 Method of determining global coagulability and hemostatic potential |
| 03/18/2004 | US20040053350 Silicone microarrays for monitoring and characterizing cholesterol, triglycerides and/or phospholipids in sample; diagnosing, preventing and treating arteriosclerosis |
| 03/18/2004 | US20040053349 Identifying and recovering preferential ligand-protein complexes via proteolysis and elimination of unliganded proteins |
| 03/18/2004 | US20040053348 Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer |
| 03/18/2004 | US20040053347 Braf35 protein and brca2/braf35 complex and methods of use |
| 03/18/2004 | US20040053346 Agent for detecting cancer's ability to metastasize |
| 03/18/2004 | US20040053345 Monitoring and prognosing effectivness of antitumor agents via presence or absence of tumor activator protein menin |
| 03/18/2004 | US20040053344 Using human leukocyte antigen protein-f to classify and identify cell proliferative disorders |
| 03/18/2004 | US20040053342 Measurement of analytes |
| 03/18/2004 | US20040053340 Protein arrays |
| 03/18/2004 | US20040053339 Sperm quality assay |
| 03/18/2004 | US20040053338 Method of identifying calcium-binding sites in gamma-crystallin useful for management of cataract |
| 03/18/2004 | US20040053337 Bioassay for monitoring interaction between lipid bilayers and test agent; high throughput assay for monitoring acyl chain mobility |
| 03/18/2004 | US20040053336 Methods for screening compound libraries |
| 03/18/2004 | US20040053335 Method for detecting prions |
| 03/18/2004 | US20040053334 Device for immobilizing cells to solid surfaces for use in measuring the interaction between proteins and/or living cells in vitro |
| 03/18/2004 | US20040053333 Identifying hidden patterns associated with serum samples which can be used to generate control models for disease; improving bioassay accuracy |
| 03/18/2004 | US20040053332 Compositions and methods for detecting proteolytic activity |
| 03/18/2004 | US20040053326 Selectively analyzing metastatic cells for differential expression of proteins |
| 03/18/2004 | US20040053325 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1) |
| 03/18/2004 | US20040053324 Assays and compositions for identifying agents that modulate the activity of deubiquitinating agents |
| 03/18/2004 | US20040053323 Method of screening inducible nitric oxide synthase activation inhibitor |
| 03/18/2004 | US20040053322 System and method for the analysis of bodily fluids |
| 03/18/2004 | US20040053321 Method for makin antibodies immunoreative with an epitope of an apolipoprotein |
| 03/18/2004 | US20040053317 Using gene patterns to diagnose and prognose tumor cells |
| 03/18/2004 | US20040053315 Identifying molecular associations using taylor-aris dispersion and changes in physical properties of molecules in flowing fluidic systems; microfluidics |
| 03/18/2004 | US20040053314 ADAM20 (SVPH1-26) DNA and polypeptides |
| 03/18/2004 | US20040053311 Methods for identifying phenotype and protein activity inhibitors |
| 03/18/2004 | US20040053309 Proteins, genes and their use for diagnosis and treatment of kidney response |
| 03/18/2004 | US20040053307 Comprises dual specificity membrane fusion proteins for treatment of transplant, allergenic, autoimmune and immunosuppressive disorders |
| 03/18/2004 | US20040053305 Substrate processing method and method for manufacturing probe carrier |
| 03/18/2004 | US20040053302 Determination of a genotype of an amplification product at multiple allelic sites |
| 03/18/2004 | US20040053300 Method and test kit for quantitative determination of variations in polynucleotide amounts in cell or tissue samples |
| 03/18/2004 | US20040053298 Composition for polymerising immobilisation of biological molecules and method for producing said composition |
| 03/18/2004 | US20040053296 Method for localizing polypeptide on cell surface |
| 03/18/2004 | US20040053295 Linear array device |
| 03/18/2004 | US20040053294 Identifying arteriosclerotic damages associated with hemodynamic shear stress via decrease in cyclophilin and tumor necrosis factor expression |
| 03/18/2004 | US20040053293 Novel core 2 beta-1,6-N-acetylglycosaminyltransferase gene |
| 03/18/2004 | US20040053291 Nucleic acid-associated proteins |
| 03/18/2004 | US20040053284 Universal multi-variant detection system |
| 03/18/2004 | US20040053281 Comprises enzymatic polypeptide associated with fatty acid metabolism for diagnosing, treating and preventing cancer, neurodegenerative, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders |
| 03/18/2004 | US20040053278 Smad6 and uses thereof |
| 03/18/2004 | US20040053277 Using microarrays to identify gene expression patterns associated with glioblastoma multiforme (GM), anaplastic astrocytoma (AA), anaplastic oligodendroglioma (AO) or oligodendroglioma (OL); prognosing metatstatic tumors |
| 03/18/2004 | US20040053271 2'-fluoropyrimidine anti-calf intestinal phosphatase nucleic acid ligands |
| 03/18/2004 | US20040053270 Identifying ribonucleoprotein complexes using fluorescent oxazolidinone or aminoglycoside reporter; antibiotic analysis |
| 03/18/2004 | US20040053265 Using differential gene expression of flotillin gene products to diagnose and prognose brain disorders |
| 03/18/2004 | US20040053262 Supressor gene |
| 03/18/2004 | US20040053261 Identifying allelic sequence whch can be used to diagnose and treat urogenital cancers |
| 03/18/2004 | US20040053259 Comprises methylated antisense oligonucleotide sequence for regulation of urokinase type plasminogen activator and treatment of cancer |
| 03/18/2004 | US20040053257 Methods for diagnosis and treatment of psychiatric disorders |
| 03/18/2004 | US20040053256 Detection signal and capture in dipstick assays |
| 03/18/2004 | US20040053255 Using chromatographic strip comprising immobilized nucleotide sequences to diagnose chlamydial infection |
| 03/18/2004 | US20040053254 Late-pcr |
| 03/18/2004 | US20040053251 Methods of screening for alzheimer's disease |
| 03/18/2004 | US20040053247 Markers for prostate cancer |
| 03/18/2004 | US20040053246 Using restriction fragment length polymorphisms and overlapping sequences to determine sequence of preferential polynucleotides; genotyping |
| 03/18/2004 | US20040053243 High purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa |
| 03/18/2004 | US20040053242 Assessment of liver fibrosis scoring with serum marker algorithms |
| 03/18/2004 | US20040053224 Monoclonal antibody specific for an epitope of inactivated feline immunodeficiency-encoded glycoprotein |
| 03/18/2004 | US20040053223 Detection of HIV-1 by nucleic acid amplification |
| 03/18/2004 | US20040053222 Nanoparticle polyanion conjugates and methods of use thereof in detecting analytes |
| 03/18/2004 | US20040053221 Diagnosing pneumocystis infection in immunocomprised individuals; immunoassay |
| 03/18/2004 | US20040053220 Replication assay for detecting anti-viral substances |
| 03/18/2004 | US20040053212 Isolating or extracting fluid from animal or plant tissues for detection of unwanted compounds such as veterinary drugs, pesticides and sugar content |